Dr. Reddy's Laboratories Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RDY research report →
Companywww.drreddys.com
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments.
- CEO
- Erez Israeli
- IPO
- 2001
- Employees
- 27,048
- HQ
- Hyderabad, IN
Price Chart
Valuation
- Market Cap
- $11.31B
- P/E
- 25.72
- P/S
- 3.28
- P/B
- 2.92
- EV/EBITDA
- 15.66
- Div Yield
- 0.61%
Profitability
- Gross Margin
- 52.77%
- Op Margin
- 14.79%
- Net Margin
- 12.76%
- ROE
- 11.76%
- ROIC
- 8.07%
Growth & Income
- Revenue
- $353.47B · 8.58%
- Net Income
- $45.09B · -20.26%
- EPS
- $53.92 · -20.53%
- Op Income
- $48.87B
- FCF YoY
- 166.85%
Performance & Tape
- 52W High
- $16.17
- 52W Low
- $12.19
- 50D MA
- $13.52
- 200D MA
- $13.92
- Beta
- 0.29
- Avg Volume
- 2.57M
Get TickerSpark's AI analysis on RDY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 1, 26 | MUNNIRPALLAM MADHU SUNDAR SUBRAMANIAN | other | 0 |
| Dec 18, 25 | AGHANIAN PATRICK RUDOLF | other | 0 |
| Dec 18, 25 | KALAWADIA MILAN KANTILAL | other | 0 |
| Dec 18, 25 | MOTUPALLI VENKATA RAMANA | other | 0 |
| Dec 18, 25 | Israeli Erez | other | 0 |
| Dec 18, 25 | VENKATESH KRISHNA | other | 0 |
| Dec 18, 25 | KULKARNI SUSHRUT | other | 0 |
| Dec 18, 25 | BHETHANABOTTLA SRINIVASA PHANIMITRA | other | 0 |
| Dec 18, 25 | MANNAM VENKATA NARASIMHAM | other | 0 |
| Dec 18, 25 | SAPRA DEEPAK | other | 0 |
Our RDY Coverage
We haven't published any research on RDY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RDY Report →